Hryz Bio Tech
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hryz Bio Tech - overview
Established
2015
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Based in Shenzhen, China and founded in 2015, Hengrui Yuanzheng (Shanghai) Biotechnology Co. ,Ltd. , dba Hryz Bio Tech, is a biotechnology company focused on the development of immune cell therapy technology for solid tumors. The company is headquartered in Shanghai and has wholly-owned subsidiaries in Shenzhen and Guangzhou.
It has applied for 46 patents of various types and has been granted 15 authorizations through PCT applications in China, the United States, Japan, Russia, and Israel. It has 10 doctoral talents, more than 50 master talents and 7 returnees. Furthermore, it passed ISO9001, ISO14001 and OHSAS18001 management system certifications in 2016 and is building a headquarters base in Songjiang, Shanghai and a regional cell preparation center in the Yangtze River Delta in 2021. In February 2026, Hryz Bio Tech closed a venture funding from Shengdi Investment and Yinglian Health Industry Fund.
Based on the Reverse Genetic Engineering TCR Screening Technology Platform (ReGET), Hryz Bio Tech develops MASCT (Multi-Antigen Stimulated Cell Therapy Injection) products, TCR-T (T Cell Receptor-Gene Engineered T Cells) immune cell products, and TCR dual antibody products. Its TCR-T product HRYZ-T101 can be used to treat cervical cancer.
Current Investors
China International Capital Corporation, HTHS Capital, Jinliang Qide (Xiamen) Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.shhryz.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Hryz Bio Tech - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.